Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ability to ...

Scientists at deCODE genetics in Iceland have discovered rare, protective loss-of-function variants that point to potential drug targets for nonalcoholic fatty liver disease (NAFLD). Scientists at ...

Cleveland Clinic is the first hospital in the world to use a recently FDA-approved ablation technology that can destroy large liver tumors. The minimally invasive procedure uses a single needle ...

SOUTH BEND, Ind. (WNDU) - It’s a first-in-the-world technique for zapping large liver tumors. Details on the treatment, in today’s Medical Moment. This year, over 40,000 people in the U.S will be ...